Blood test to track ALS progression
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study is looking for biological markers in the blood that can help monitor how ALS progresses and potentially detect it earlier. By participating, you may help improve future diagnosis and care for ALS patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ALS by a doctor using standard criteria.
- Your ALS can be either inherited (familial) or not (sporadic).
- Your ALS can start in either the limbs or the bulbar muscles (affecting speech and swallowing).
- You are willing to provide blood samples for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at platelets (tiny blood cells that help clotting) in people with ALS to find a way to diagnose the disease earlier. If you've been recently diagnosed with ALS or another motor neuron disease, your blood sample could help researchers develop a simple test.
This study screens people with ALS to see if they might qualify for future gene-targeted treatments. It helps match you to trials that may be a good fit for your genetic type.
This study collects blood, skin, and urine samples from people with ALS to build a cell bank and look for biomarkers—natural signs that might help track the disease or guide future treatments. It doesn't test a new drug, but it helps researchers learn more about ALS.
This study is looking for people with ALS to help doctors understand how certain biological markers (biomarkers) change over time. It involves a lumbar puncture (spinal tap) to collect fluid from your spine and regular check-ups.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study looks at a blood test to help doctors diagnose ALS (Lou Gehrig's disease). It tests a protein called neurofilaments that may show nerve damage. The study is for people suspected of having ALS, and the blood sample is taken as part of normal care.
Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.